nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0712	0.15	CcSEcCtD
Telaprevir—CTSK—forelimb—amyotrophic lateral sclerosis	0.0681	0.173	CbGeAlD
Telaprevir—CTSK—hindlimb—amyotrophic lateral sclerosis	0.0613	0.156	CbGeAlD
Telaprevir—CTSK—appendage—amyotrophic lateral sclerosis	0.0525	0.134	CbGeAlD
Telaprevir—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0371	0.0781	CcSEcCtD
Telaprevir—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.034	0.0716	CcSEcCtD
Telaprevir—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0318	0.067	CcSEcCtD
Telaprevir—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0577	CcSEcCtD
Telaprevir—CELA1—nervous system—amyotrophic lateral sclerosis	0.025	0.0634	CbGeAlD
Telaprevir—CELA1—central nervous system—amyotrophic lateral sclerosis	0.024	0.0611	CbGeAlD
Telaprevir—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.021	0.0442	CcSEcCtD
Telaprevir—CELA1—brain—amyotrophic lateral sclerosis	0.0191	0.0485	CbGeAlD
Telaprevir—Gout—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0392	CcSEcCtD
Telaprevir—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0166	0.035	CcSEcCtD
Telaprevir—CTSS—embryo—amyotrophic lateral sclerosis	0.0153	0.0388	CbGeAlD
Telaprevir—Eczema—Riluzole—amyotrophic lateral sclerosis	0.014	0.0296	CcSEcCtD
Telaprevir—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0242	CcSEcCtD
Telaprevir—CTSK—medulla oblongata—amyotrophic lateral sclerosis	0.0111	0.0283	CbGeAlD
Telaprevir—CTSK—spinal cord—amyotrophic lateral sclerosis	0.00994	0.0253	CbGeAlD
Telaprevir—CTSS—medulla oblongata—amyotrophic lateral sclerosis	0.00977	0.0248	CbGeAlD
Telaprevir—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00972	0.0205	CcSEcCtD
Telaprevir—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00972	0.0205	CcSEcCtD
Telaprevir—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00919	0.0194	CcSEcCtD
Telaprevir—CTSS—spinal cord—amyotrophic lateral sclerosis	0.00871	0.0221	CbGeAlD
Telaprevir—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0182	CcSEcCtD
Telaprevir—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0181	CcSEcCtD
Telaprevir—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00855	0.018	CcSEcCtD
Telaprevir—CTSK—nervous system—amyotrophic lateral sclerosis	0.00838	0.0213	CbGeAlD
Telaprevir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00825	0.0174	CcSEcCtD
Telaprevir—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00816	0.0172	CcSEcCtD
Telaprevir—CTSK—central nervous system—amyotrophic lateral sclerosis	0.00807	0.0205	CbGeAlD
Telaprevir—CTSK—MHC class II antigen presentation—KIFAP3—amyotrophic lateral sclerosis	0.00789	0.0598	CbGpPWpGaD
Telaprevir—CTSK—cerebellum—amyotrophic lateral sclerosis	0.00788	0.02	CbGeAlD
Telaprevir—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0076	0.016	CcSEcCtD
Telaprevir—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00744	0.0157	CcSEcCtD
Telaprevir—CTSS—nervous system—amyotrophic lateral sclerosis	0.00734	0.0187	CbGeAlD
Telaprevir—CTSS—central nervous system—amyotrophic lateral sclerosis	0.00707	0.018	CbGeAlD
Telaprevir—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00702	0.0148	CcSEcCtD
Telaprevir—CTSS—cerebellum—amyotrophic lateral sclerosis	0.00691	0.0176	CbGeAlD
Telaprevir—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00681	0.0144	CcSEcCtD
Telaprevir—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00668	0.0141	CcSEcCtD
Telaprevir—CTSS—MHC class II antigen presentation—KIFAP3—amyotrophic lateral sclerosis	0.00649	0.0492	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00642	0.0135	CcSEcCtD
Telaprevir—CTSK—brain—amyotrophic lateral sclerosis	0.0064	0.0163	CbGeAlD
Telaprevir—Infection—Riluzole—amyotrophic lateral sclerosis	0.00616	0.013	CcSEcCtD
Telaprevir—Shock—Riluzole—amyotrophic lateral sclerosis	0.0061	0.0129	CcSEcCtD
Telaprevir—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0128	CcSEcCtD
Telaprevir—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0128	CcSEcCtD
Telaprevir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0127	CcSEcCtD
Telaprevir—CTSS—brain—amyotrophic lateral sclerosis	0.00561	0.0143	CbGeAlD
Telaprevir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0113	CcSEcCtD
Telaprevir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0113	CcSEcCtD
Telaprevir—ORM1—spinal cord—amyotrophic lateral sclerosis	0.0052	0.0132	CbGeAlD
Telaprevir—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0104	CcSEcCtD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—SQSTM1—amyotrophic lateral sclerosis	0.00487	0.0369	CbGpPWpGaD
Telaprevir—CTSK—MHC class II antigen presentation—DCTN1—amyotrophic lateral sclerosis	0.00465	0.0352	CbGpPWpGaD
Telaprevir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00938	CcSEcCtD
Telaprevir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00924	CcSEcCtD
Telaprevir—ORM1—nervous system—amyotrophic lateral sclerosis	0.00438	0.0111	CbGeAlD
Telaprevir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00894	CcSEcCtD
Telaprevir—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00422	0.0107	CbGeAlD
Telaprevir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00864	CcSEcCtD
Telaprevir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00831	CcSEcCtD
Telaprevir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00824	CcSEcCtD
Telaprevir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00823	CcSEcCtD
Telaprevir—CTSS—MHC class II antigen presentation—DCTN1—amyotrophic lateral sclerosis	0.00383	0.029	CbGpPWpGaD
Telaprevir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00776	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00336	0.0255	CbGpPWpGaD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—amyotrophic lateral sclerosis	0.00299	0.0227	CbGpPWpGaD
Telaprevir—ALB—brain—amyotrophic lateral sclerosis	0.00294	0.00746	CbGeAlD
Telaprevir—ABCB1—embryo—amyotrophic lateral sclerosis	0.0027	0.00685	CbGeAlD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—amyotrophic lateral sclerosis	0.00267	0.0202	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00255	0.0193	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00233	0.0177	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—MMP9—amyotrophic lateral sclerosis	0.00232	0.0176	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.0023	0.0174	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.00215	0.0163	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.00197	0.0149	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00193	0.0146	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00189	0.0143	CbGpPWpGaD
Telaprevir—CMA1—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00188	0.0143	CbGpPWpGaD
Telaprevir—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00183	0.00465	CbGeAlD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00179	0.0135	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.00177	0.0134	CbGpPWpGaD
Telaprevir—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00176	0.00448	CbGeAlD
Telaprevir—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00172	0.00438	CbGeAlD
Telaprevir—CMA1—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00159	0.0121	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00156	0.0118	CbGpPWpGaD
Telaprevir—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00391	CbGeAlD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—amyotrophic lateral sclerosis	0.00149	0.0113	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—CASP3—amyotrophic lateral sclerosis	0.0014	0.0106	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00134	0.0102	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP9—amyotrophic lateral sclerosis	0.00132	0.01	CbGpPWpGaD
Telaprevir—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00129	0.00329	CbGeAlD
Telaprevir—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00126	0.00955	CbGpPWpGaD
Telaprevir—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00317	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—CASP3—amyotrophic lateral sclerosis	0.00125	0.00944	CbGpPWpGaD
Telaprevir—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00122	0.0031	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP9—amyotrophic lateral sclerosis	0.00118	0.00892	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00115	0.0087	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00114	0.00863	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.00112	0.00845	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0011	0.00834	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00103	0.00779	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—CASP3—amyotrophic lateral sclerosis	0.00103	0.00777	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—MMP9—amyotrophic lateral sclerosis	0.00102	0.00769	CbGpPWpGaD
Telaprevir—ABCB1—brain—amyotrophic lateral sclerosis	0.00099	0.00252	CbGeAlD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00098	0.00742	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP9—amyotrophic lateral sclerosis	0.000969	0.00734	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000945	0.00716	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000926	0.00702	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000919	0.00696	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000917	0.00695	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000914	0.00692	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000882	0.00668	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000841	0.00637	CbGpPWpGaD
Telaprevir—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000724	0.00549	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000696	0.00527	CbGpPWpGaD
Telaprevir—CTSK—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000677	0.00513	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000663	0.00502	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000642	0.00486	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000637	0.00482	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000602	0.00456	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000585	0.00444	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000573	0.00434	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000567	0.0043	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000566	0.00429	CbGpPWpGaD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000564	0.00427	CbGpPWpGaD
Telaprevir—CTSS—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000557	0.00422	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000553	0.00419	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000551	0.00418	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000546	0.00414	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000545	0.00413	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000537	0.00407	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000524	0.00397	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000522	0.00396	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000522	0.00395	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00052	0.00394	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000512	0.00388	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000493	0.00374	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000481	0.00365	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000474	0.00359	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000471	0.00357	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000467	0.00354	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000462	0.0035	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000456	0.00346	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000456	0.00346	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000453	0.00343	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000449	0.0034	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000449	0.0034	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000448	0.00339	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000442	0.00335	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000432	0.00328	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.00043	0.00326	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000426	0.00323	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000422	0.0032	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000415	0.00314	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000411	0.00311	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000407	0.00309	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000406	0.00308	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ATF1—amyotrophic lateral sclerosis	0.000405	0.00307	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000388	0.00294	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CASP9—amyotrophic lateral sclerosis	0.000386	0.00293	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000373	0.00283	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000373	0.00282	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000372	0.00282	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000356	0.0027	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000356	0.00269	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000355	0.00269	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000346	0.00263	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000339	0.00257	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ATF1—amyotrophic lateral sclerosis	0.000334	0.00253	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB4—amyotrophic lateral sclerosis	0.00033	0.0025	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000326	0.00247	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CASP9—amyotrophic lateral sclerosis	0.000318	0.00241	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000317	0.0024	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000314	0.00238	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000314	0.00238	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000311	0.00235	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000309	0.00234	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.0003	0.00227	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000294	0.00223	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000294	0.00223	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000286	0.00216	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000282	0.00214	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000282	0.00214	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00028	0.00212	CbGpPWpGaD
Telaprevir—CTSK—Immune System—C3—amyotrophic lateral sclerosis	0.000275	0.00208	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000273	0.00207	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000272	0.00206	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00026	0.00197	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000257	0.00195	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000256	0.00194	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00024	0.00182	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000235	0.00178	CbGpPWpGaD
Telaprevir—CTSS—Immune System—C3—amyotrophic lateral sclerosis	0.000226	0.00171	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000225	0.00171	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000223	0.00169	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000219	0.00166	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000218	0.00165	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000212	0.0016	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00021	0.00159	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000199	0.00151	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000199	0.0015	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000189	0.00143	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000186	0.00141	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000185	0.00141	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000184	0.00139	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000182	0.00138	CbGpPWpGaD
Telaprevir—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000181	0.00138	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000181	0.00138	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000178	0.00135	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000178	0.00135	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000175	0.00133	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.00017	0.00129	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000169	0.00128	CbGpPWpGaD
Telaprevir—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000166	0.00126	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000166	0.00126	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000161	0.00122	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000161	0.00122	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000159	0.0012	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000159	0.0012	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000158	0.0012	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000157	0.00119	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000154	0.00117	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000153	0.00116	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000145	0.0011	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000145	0.0011	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000143	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000141	0.00107	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000141	0.00107	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000135	0.00102	CbGpPWpGaD
Telaprevir—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000131	0.000994	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000128	0.000969	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000127	0.000963	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000126	0.000955	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000126	0.000952	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000121	0.000917	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000119	0.000903	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000118	0.000894	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000115	0.000871	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000111	0.000845	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000102	0.000776	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.0001	0.000758	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	9.94e-05	0.000753	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.89e-05	0.000749	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.8e-05	0.000742	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.8e-05	0.000742	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	9.18e-05	0.000696	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.18e-05	0.000695	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	9.18e-05	0.000695	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.96e-05	0.000679	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.71e-05	0.00066	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.36e-05	0.000633	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.33e-05	0.000631	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	8.04e-05	0.000609	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	7.91e-05	0.000599	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.83e-05	0.000593	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.79e-05	0.00059	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.56e-05	0.000573	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	7.54e-05	0.000571	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.08e-05	0.000537	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.88e-05	0.000521	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.6e-05	0.0005	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.24e-05	0.000473	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.88e-05	0.000446	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.37e-05	0.000407	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.95e-05	0.000375	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.71e-05	0.000357	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.08e-05	0.000309	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.07e-05	0.000308	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.05e-05	0.000307	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.72e-05	0.000282	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.55e-05	0.000269	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.26e-05	0.000247	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	3.08e-05	0.000233	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	3.06e-05	0.000232	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.68e-05	0.000203	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.19e-05	0.000166	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.1e-05	0.000159	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	0.000152	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.84e-05	0.000139	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.65e-05	0.000125	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	8.58e-05	CbGpPWpGaD
